Showing results (231-240 of 427) with videos related to

Sort By:
Pageof 43
Clinical Breast Cancer|June 28, 2006
Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessonsHarold J Burstein, Erica Mayer, Ann H Patridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinomaM N Fornier, A D Seidman, M Theodoulou, et al.
JAMA|March 3, 2005
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancerHyman B Muss, Susan Woolf, Donald Berry, et al.
Breast Cancer Research and Treatment|October 24, 2007
Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancerT A Traina, I Poggesi, M Robson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2014
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancerJ Baselga, A Manikhas, J Cortés, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2008
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840Andrew D Seidman, Donald Berry, Constance Cirrincione, et al.
Annals of Surgery|October 8, 2015
Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated PatientsEran Sadot, Ser Yee Lee, Constantinos T Sofocleous, et al.
Breast Cancer Research and Treatment|December 27, 2011
A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancerHope S Rugo, A Jo Chien, Sandra X Franco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2015
Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast CancerNeil M Iyengar, Xi Kathy Zhou, Ayca Gucalp, et al.
Cancer|August 11, 2016
White adipose tissue inflammation and cancer-specific survival in patients with squamous cell carcinoma of the oral tongueNeil M Iyengar, Ronald A Ghossein, Luc G Morris, et al.
Pageof 43